Inhibiting transmission of respiratory viruses
Phase 2
- Registration Number
- CTRI/2020/10/028255
- Lead Sponsor
- Dr Suman Kapur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Persons not having COVID-19 but quarantined for possible infection with SARS-COV-2, and persons involved in community care (first-line workers)
Exclusion Criteria
Persons suffering from any sign or symptom of COVID-19, uncontrolled Diabetes, acute cardiovascular diseases, and any life threatening co-morbid condition
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Absence of symptoms of acute respiratory distressTimepoint: 14 days from day of quarantine
- Secondary Outcome Measures
Name Time Method egative for SARS-Cov2 RT-PCR based testTimepoint: 14 days from day of quarantine